A simple dilute-and-shoot procedure for the determination of platinum in human pleural effusions using HR-CS GF-AAS

Autoři

ZVĚŘINA Ondřej VENCLÍČEK Ondřej KUTA Jan COUFALÍK Pavel HAGAROVÁ Ingrid BRAT Kristián

Rok publikování 2021
Druh Článek v odborném periodiku
Časopis / Zdroj Journal of Trace Elements in Medicine and Biology
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://www.sciencedirect.com/science/article/pii/S0946672X21001590?dgcid=author
Doi http://dx.doi.org/10.1016/j.jtemb.2021.126869
Klíčová slova Lung cancer; Platinum; Pleural effusion; HR-CS GF-AAS
Popis Background High-resolution continuum source AAS is an emerging technique for the determination of trace elements in clinical analysis. We aimed to develop a method for the direct determination of platinum (Pt) in pleural effusions that could deepen the understanding of the dynamics of intrapleural Pt concentration during cytostatic therapy. Materials and methods Samples were collected by thoracic drainage from five patients with lung cancer undergoing platinum based chemotherapy. A simple dilute-and-shoot method for Pt determination in the pleural effusions was developed. Ashing of the sample in an oxygen flow in a graphite tube allowed for direct analysis without prior mineralization. The trueness of the method was verified using an independent technique (ICP-MS). As platinum derivatives are only active in its free form (not bound to proteins), Pt in samples was further divided into free and protein-bound forms by means of ultrafiltration. Results Using the proposed method, Pt contents (free and total) were determined in samples collected at different times after the intravenous application of the Pt derivative. The concentration of total Pt reached values of up to 5,000 µg/L and different patterns of its dynamics in intrapleural fluid were observed. Conclusions The developed method enables the fast and simple determination of Pt in biological fluids. It may be applied on a large scale to improve the understanding of Pt dynamics during cytostatic therapy, and also to determine the optimal timing of both thoracic drainage and administration of systemic chemotherapy.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info